Literature DB >> 19712707

Fragment analogs as better mimics of obestatin.

ShreeRanga Nagaraj1, Muthukumar S Peddha, Uma V Manjappara.   

Abstract

Obestatin is a twenty three amino acid peptide produced in the stomach by post translational modification of the preproghrelin gene. Since its discovery in 2005, many studies have shown that obestatin reduces feed intake and gain in body weight in rodents. Studies from our laboratory have shown the N-terminal thirteen residues mimic obestatin the best and residues 6-18 reduce epididymal fat significantly in adult male mice. In this study we have tried to increase the efficacy of these fragments. As an initial step, we have substituted G(8) with alpha-aminoisobutyricacid(Aib,U) and F(5) with cyclohexylalanine(Cha) in the N-terminal peptide to obtain two modified peptides and modified the middle fragment (residues 6-18) by substituting both the glycine residues at position 3 and 8 with alpha-aminoisobutyricacid(U). The rationale being, unusual amino acids could protect the peptides from immediate degradation and Aib would also induce secondary structure in these unstructured peptides. The N-terminal fragment with the G(8)U substitution fared the best. It reduced food intake, gain in body weight, levels of cholesterol and triglycerides in the blood, epididymal and perirenal fat in adult male mice similar to that of obestatin. The middle fragment with G(3,8)U double substitution was the second best.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712707     DOI: 10.1016/j.regpep.2009.08.008

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  5 in total

1.  Effects of single intranasal administration of obestatin fragments on the body weight and feeding and drinking behaviors.

Authors:  E E Khirazova; M V Maslova; E S Motorykina; D A Frid; A V Graf; A S Maklakova; N A Sokolova; A A Kamenskii
Journal:  Dokl Biol Sci       Date:  2014-01-03

2.  Obestatin and Rosiglitazone Differentially Modulate Lipid Metabolism Through Peroxisome Proliferator-activated Receptor-γ (PPARγ) in Pre-adipose and Mature 3T3-L1 Cells.

Authors:  Mallikarjuna B G; Uma V Manjappara
Journal:  Cell Biochem Biophys       Date:  2021-01-11       Impact factor: 2.194

3.  Treatment of lean and diet-induced obesity (DIO) mice with a novel stable obestatin analogue alters plasma metabolite levels as detected by untargeted LC-MS metabolomics.

Authors:  Brian D Green; Stewart F Graham; Elaine Cowan; Praveen Kumar; Kerry J Burch; David J Grieve
Journal:  Metabolomics       Date:  2016-07-05       Impact factor: 4.290

Review 4.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

5.  Serum ghrelin, but not obestatin, is a potential predictor of acute pancreatitis severity.

Authors:  Huilin Wang; Mengbin Qin; Zhihai Liang; Renjie Chang; Hongzong Fu; Yule Wei; Guodu Tang
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.